ArticleFrontiers in oncology2025
Time trends in colorectal cancer incidence across the BRICS: an age-period-cohort analysis for the GBD 2021.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colorectal cancer (CRC) is a leading global health burden, contributing significantly to disability-adjusted life years and economic burden. The BRICS nations-spanning diverse and rapidly evolving socio-economic contexts-are undergoing critical epidemiological transitions. Understanding CRC trends in these countries is essential to inform targeted control strategies. Methods: Data from the Global Burden of Disease (GBD) 2021 database were used to assess trends in CRC incidence across BRICS countries from 1990 to 2021. An age-period-cohort (APC) model with the intrinsic estimator (IE) algorithm was employed to disentangle the independent effects of age, period, and cohort on incidence rates. Data were stratified into 5-year age groups, and 95% uncertainty intervals (UIs) were calculated to reflect variability and estimation precision. Results: From 1990 to 2021, the global CRC cases increased by 139.38%, with the age-standardized incidence rate (ASIR) rising by 6.52%. Among BRICS nations, Saudi Arabia had the largest increase in cases (111.02%), while United Arab Emirates showed a decline (-23.04%). Globally, most age groups exhibited positive local drift values, indicating rising incidence rates, except for individuals under 20 years. This pattern was also observed in India and South Africa, whereas Ethiopia showed a distinct trend. Brazil, China, Egypt, Iran, and Saudi Arabia experienced consistent increases across nearly all age groups. The age effect revealed a low CRC risk before age 35-39, with risk rising steadily and peaking at age 90-94, a pattern consistent across all countries. Period effects were relatively stable globally, with increasing trends in all BRICS nations except Ethiopia. Cohort effects generally increased over time, stabilizing in recent birth cohorts, with a steeper rise among males. However, India and Ethiopia showed declining cohort risks. Conclusion: This study highlights a substantial global increase in CRC incidence, with notable variations across BRICS nations over the past three decades. The observed age, period, and cohort effects underscore the need for age-specific and gender-sensitive health policies. Ongoing surveillance, research, and targeted public health interventions are critical to mitigating the rising CRC burden and improving health outcomes in these rapidly evolving regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.